“Being able to monitor pressure over time based on natural filling cycles will be a gamechanger in the field of urology.”
- Dr Lennart Wagrell, Renowned Urologist
WHAT THE INDUSTRY IS SAYING
Dr. Glyn Burtt
Former Medical Director at Boston Scientific
Dr. Glyn Burtt, Medical Director at Boston Scientific until recently, is a big fan too. In this video he explains how PRESSURO can help to select the right candidates for the different surgical treatments Boston Scientific offers.
PATIENT GROUP
Enlarged Prostate
Benign Prostatic Hyperplasia
307 Million Worldwide
The PRESSURO® Benefit
Understand the degree of obstruction
Identify candidates who will benefit from surgery
Prevent bladder collapse
CLINICAL PARTNER
Prof. Dr. med. Jorge Rioja
Focusing on the Benign Prostatic Hyperplasia (BPH) patient group
University of Zaragoza in Spain
For patients with BPH, PRESSURO will provide new insight to those who present with filling symptoms as well as hypotonic bladders. This insight will be used to determine whether surgery is the correct treatment. PRESSURO will provide insight before, during and after treatment.
PATIENT GROUP
Incontinence
Urinary Incontinence
423 Million Worldwide
The PRESSURO® Benefit
Understand if the problem originates from urge or stress incontinence
Identify candidates who will benefit from (sling) surgery or medical treatment
Monitor the bladder’s natural pressure over time to detect infrequent bladder behavior which is the source of the problem.
CLINICAL PARTNER
Prof. Dr. med. Oliver Hakenberg
Focusing on Neurogenic patient group
Rostock University in Germany
By measuring natural bladder pressure over time, urologists can detect the origin of the problem in a way not possible before. We can differentiate between various types of incontinence and overactive bladder and determine the most appropriate course of treatment for each patient.
PATIENT GROUP
Neurogenic Bladder
Neurogenic bladder
135 Million Worldwide
The PRESSURO® Benefit
Prevent kidney failure, a life-threatening condition
Decide on the best treatment
Detect high pressure events
Prof. Dr. med. Oliver Hakenberg
Focusing on Neurogenic patient group
Rostock University in Germany
Patients with Spinal Cord Injury, MS, Parkinson’s can develop neurogenic bladders. They are at a higher risk of kidney damage which can be life threatening. PRESSURO can provide up to 30 days of bladder pressure monitoring to help determine further treatments.
PATIENT GROUP
Children with Urinary Dysfunction
Children with Voiding Problems
20 Million Worldwide
The PRESSURO® Benefit
Provide new functional insight that is not available using today’s method
PRESSURO® avoids fragile urethra in children
CLINICAL PARTNER
Prof. Dr. med. Jens Rassweiler
Focusing on children suffering from filling and voiding problems
Klinikum Heilbronn, the academic hospital of Heidelberg University
For children, PRESSURO will offer new possibilities of functional insight which has not been available to this group before due to the delicate nature of their developing systems. The goal is to eliminate the trial and error methods of medications and treatments currently used by using our new insight.
PRESSURO®
Network of more than 20 urologists (KOLs) across Europe
More than 20 leading urologists around the world are on the waiting list to use PRESSURO®. We have selected some of the best clinicians to lead our clinical trials.